-transparent.png){kind=logo}
Drug treatment of horses which are used in horse-racing is restricted by the regulations of the anti-doping control. Veterinarians and anti-doping control commissions are faced with the problems resulting from the discrepancy between the demand "no drugs in blood/urine of horses at the time of competition" and the need for treatment. The pharmacokinetic data of important antiphlogistics/analgetics (NSAID) for horses given in this article shall facilitate the decision of the veterinarians and commissions whether a horse having been treated with NSAID may participate in a competition or not. Further a new concept of anti-doping regulation of therapeutic substances is presented for discussion.
A M Klaus, and
H J Hapke
April 2017,
Schweizer Archiv fur Tierheilkunde,
A M Klaus, and
H J Hapke
October 1984,
Schweizerische Monatsschrift fur Zahnmedizin = Revue mensuelle suisse d'odonto-stomatologie = Rivista mensile svizzera di odontologia e stomatologia,
A M Klaus, and
H J Hapke
September 2003,
Journal of endocrinological investigation,
A M Klaus, and
H J Hapke
April 2022,
Gene therapy,
A M Klaus, and
H J Hapke
February 1988,
Osterreichische Zahnarzts-Zeitung; Mitteilungen der Bundesfachgruppe fur Zahnheilkunde der Osterreichischen Arztekammer,
A M Klaus, and
H J Hapke
January 1986,
Dermatologische Monatschrift,
A M Klaus, and
H J Hapke
January 1974,
Zeitschrift fur Alternsforschung,
